EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Ceramides are fuel gauges on the drive to cardiometabolic disease

Joseph L Wilkerson, Sean M Tatum iD, William L Holland, Scott A Summers iD

Physiological Reviews · 01.07.2024 · 104 (3) · 1061-1119

DOI: 10.1152/physrev.00008.2023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.07.2024. Verfasst von Joseph L Wilkerson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States. Hauptthemen laut MEDLINE: Ceramides, Cardiovascular Diseases. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 618 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, Ben B. and Iris M. Margolis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceramides are signals of fatty acid excess that accumulate when a cell’s energetic needs have been met and its nutrient storage has reached capacity. As these sphingolipids accrue, they alter the metabolism and survival of cells throughout the body including in the heart, liver, blood vessels, skeletal muscle, brain, and kidney. These ceramide actions elicit the tissue dysfunction that underlies cardiometabolic diseases such as diabetes, coronary artery disease, metabolic-associated steatohepatitis, and heart failure. Here, we review the biosynthesis and degradation pathways that maintain ceramide levels in normal physiology and discuss how the loss of ceramide homeostasis drives cardiometabolic pathologies. We highlight signaling nodes that sense small changes in ceramides and in turn reprogram cellular metabolism and stimulate apoptosis. Finally, we evaluate the emerging therapeutic utility of these unique lipids as biomarkers that forecast disease risk and as targets of ceramide-lowering interventions that ameliorate disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesCardiovascular DiseasesHumansAnimalsMetabolic Diseases

Stichwörter der Autor:innen

ceramidesdiabeteslipotoxicitymetabolic diseasesphingolipids

Substanzen

Ceramides

Autor:innen und Institutionen

  • Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States.

ORCID-Profile: Sean M Tatum, Scott A Summers

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • Ben B. and Iris M. Margolis Foundation
  • HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases
  • American Diabetes Association
  • American Heart Association

Zitieren

APA

Wilkerson, J. L., Tatum, S. M., Holland, W. L., & Summers, S. A. (2024). Ceramides are fuel gauges on the drive to cardiometabolic disease. Physiological Reviews, 104(3), 1061-1119. https://doi.org/10.1152/physrev.00008.2023

Vancouver

Wilkerson JL, Tatum SM, Holland WL, Summers SA. Ceramides are fuel gauges on the drive to cardiometabolic disease. Physiological Reviews. 2024;104(3):1061-1119. doi:10.1152/physrev.00008.2023

BibTeX
@article{Wilkerson2024,
  author = {Wilkerson, Joseph L and Tatum, Sean M and Holland, William L and Summers, Scott A},
  title = {Ceramides are fuel gauges on the drive to cardiometabolic disease},
  journal = {Physiological Reviews},
  year = {2024},
  volume = {104},
  number = {3},
  pages = {1061--1119},
  doi = {10.1152/physrev.00008.2023}
}
Kostenlos starten →